Systemic administration of liposomal encapsulated [beta]- galactosidase: a model to investigate the development of therapeutic protein drug
With advances in recombinant protein technology, a growing number of therapeutic protein products have become available for clinical applications. But their wide use is limited by poor biodistribution, limited circulation time and the generation of immune responses to the drug by the patient. The...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
2009
|
| Online Access: | http://hdl.handle.net/2429/7783 |